Data / Form D filings / Slate Medicines, Inc.
Slate Medicines, Inc.: Form D filing
Slate Medicines, Inc., a pharmaceuticals company in Boston, MA, filed a Form D with the SEC in 2026. The latest, on March 11, 2026, reports $10 million sold of a $130 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 BERKELEY STREET, 18TH FLOOR, Boston, MA, 02116
- Phone
- (617) 778-2500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2117806
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | New notice | $130,000,000 | $9,999,992 | $120,000,008 | 6 | Feb 17, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Levin | Director | |
| Cindy Xiong | Director | |
| Tim Lohoff | Director | |
| Neil Buckley | Executive Officer, Director | |
| Sara Pacheco | Executive Officer | |
| Gregory Frank Oakes | Executive Officer |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Mar 9, 2026 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Slate Medicines, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.